Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - VG Life Sciences Inc.Financial_Report.xls
10-Q - FORM 10-Q - VG Life Sciences Inc.vglife_10q-093014.htm
EX-10.102 - CONVERTIBLE DEBENTURE - VG Life Sciences Inc.vglife_10q-ex10102.htm
EX-10.128 - CONVERTIBLE DEBENTURE - VG Life Sciences Inc.vglife_10q-ex10128.htm
EX-10.132 - CONVERTIBLE DEBENTURE - VG Life Sciences Inc.vglife_10q-ex10132.htm
EX-10.131 - CONVERTIBLE PROMISSORY NOTE AND WARRANT PURCHASE AGREEMENT - VG Life Sciences Inc.vglife_10q-ex10131.htm
EX-10.143 - NOTICE OF CONVERSION - VG Life Sciences Inc.vglife_10q-ex10143.htm
EX-31.2 - CERTIFICATION - VG Life Sciences Inc.vglife_10q-ex3102.htm
EX-10.148 - CONVERTIBLE PROMISSORY NOTE - VG Life Sciences Inc.vglife_10q-ex10148.htm
EX-31.1 - CERTIFICATION - VG Life Sciences Inc.vglife_10q-ex3101.htm
EX-10.113 - CONVERTIBLE DEBENTURE - VG Life Sciences Inc.vglife_10q-ex10113.htm
EX-10.149 - WARRANT - VG Life Sciences Inc.vglife_10q-ex10149.htm
EX-10.150 - CONVERTIBLE PROMISSORY NOTE - VG Life Sciences Inc.vglife_10q-ex10150.htm
EX-10.151 - WARRANT - VG Life Sciences Inc.vglife_10q-ex10151.htm
EX-10.127 - CONVERTIBLE DEBENTURE - VG Life Sciences Inc.vglife_10q-ex10127.htm
EX-10.80 - CONVERTIBLE DEBENTURE - VG Life Sciences Inc.vglife_10q-ex10080.htm
EX-10.116 - RELEASE AND SETTLEMENT AGREEMENT - VG Life Sciences Inc.vglife_10q-ex10116.htm

Exhibit 32.1

  

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officers of VG Life Sciences Inc., a Delaware corporation (the “Company”), do hereby certify, to such officers’ knowledge, that:

 

The Quarterly Report on Form 10-Q for the quarter ended September 30, 2014 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: November 13, 2014 By: /s/ John Tynan  
   

John Tynan

Chief Executive Officer

(Principal Executive Officer)

 
       
Date: November 13, 2014 By: /s/ David Odell  
   

David Odell

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)